Drugs / PCV-13 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01443117 | ? → Aug 2014 | HIV infectious disease, pneumococcal infection | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PCV-13 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01443117 ↗ |
| Modality | Vaccine | “PCV-13 vaccine” NCT01443117 ↗ |
| Route | Intramuscular | “Administered as a 0.5 mL IM dose” NCT01443117 ↗ |